Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class III · Low risk Ongoing Initiated Feb 20, 2024 (3 years ago)

Clindamycin Phosphate Topical Solution USP

Class III — Low risk. Unlikely to cause harm, but violates FDA regulations.

Why it was recalled

Defective Container: Out of specification for weight due to a slow leakage at the 12-month stability timepoint.

Cause type: Packaging defect

Failed child-resistant closures, leaks, cracked containers, or a defective delivery device. Packaging failures risk accidental exposure (especially to children) or product contamination. All packaging defect recalls.

What was recalled

Clindamycin Phosphate Topical Solution USP, 1%, 60 mL bottle, Manufactured for: Glasshouse Pharmaceuticals Limited Canada, Mississauga, Ontario, Canada, L5N 6R8, NDC 71428-0003-60

Affected NDC 71428-0003-60

Compare with the code on your package — it is the most precise check available.

Drug: Clindamycin Category: Antibiotic

Recalling firm
Contract Pharmaceuticals Limited Canada
NDC code
71428-0003-60
Origin
Canada
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0365-2024 · FDA notice

Low risk, still worth a check. Class III means the product is unlikely to cause harm but breaks an FDA rule (often labeling). If your lot matches, your pharmacy will normally swap it; there is no need for alarm.

Other Clindamycin recalls

See all

Other recalls by Contract Pharmaceuticals Limited Canada

All 2024 recalls
Class III · Low risk

Clindamycin Phosphate

Defective Container: Out of specification for weight due to a slow leakage at the 12-month stability timepoint.

Ongoing Packaging defect Contract Pharmaceuticals Limited Canada NDC 10135-0691-61 D-0364-2024